Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

4,023 public trials 395 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD

NCT02766608

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disorder, Disease Attributes, +6 more
Locations
  • Research Site Athens, Alabama, United States
  • Research Site Birmingham, Alabama, United States
  • Research Site Dothan, Alabama, United States
  • Research Site Phoenix, Arizona, United States
View all 259 locations
View Trial Details
Completed

A Randomized, Multicenter, Open-label, Parallel-group, 12-week Study to Assess the Efficacy and Safety of Switching From Tiotropium to QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) in Symptomatic Mild to Moderate COPD Patients

NCT02566031

Conditions
COPD, Chronic Disease, Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Chuncheon, Gangwon-do, South Korea
  • Novartis Investigative Site Wŏnju, Gangwon-do, South Korea
  • Novartis Investigative Site Anyang-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Guri-si, Gyeonggi-do, South Korea
View all 24 locations
View Trial Details
Completed

A Study to Evaluate the Effects of ACT-541468 on Respiration in Patients With Moderate Chronic Obstructive Pulmonary Disease

NCT03646864

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Advanced Sleep Research Berlin, Germany
  • Klinische Forschungsgruppe Nord Dresden, Germany
  • Klinische Forschungsgruppe Nord Hanover, Germany
  • framol-med GmbH, Lungenpraxis Rheinau, Germany
View Trial Details
Completed

Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00671073

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Forest Investigative Site Birmingham, Alabama, United States
  • Forest Investigative Site Phoenix, Arizona, United States
  • Forest Investigative Site Tucson, Arizona, United States
  • Forest Investigative Site Buena Park, California, United States
View all 47 locations
View Trial Details
Completed

Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD

NCT00157339

Conditions
Asthma, Bronchial Diseases, Chronic Disease, +16 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montgomery, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Burbank, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenbrae, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Norwich, Connecticut, United States
View all 101 locations
View Trial Details
Completed

Chronic Obstructive Pulmonary Disease

NCT03577080

Conditions
COPD, Chronic Disease, Disease Attributes, +6 more
Locations
  • Research Unit of Exercise Physiology and Pathophysiology: from integral to molecular Biology, Medicine and Health (UR12 ES06) Faculty of Medicine of Sousse Sousse, Tunisia
View Trial Details

Related conditions